Quantcast

Latest Ascites Stories

2010-01-15 08:10:00

CLAREMONT, Calif., Jan. 15 /PRNewswire/ -- Anti-Cancer Institute (ACI) introduces PANLIAN Concentrate, a medicinal herbal supplement proven to aid in combating tumors. PANLIAN, a natural herb, is primarily grown in China's Guizhou high plateau at 3,000 meters above sea level. PANLIAN likes to grow in the crevices of Guizhou's mountain cliffs. According to several medicinal herbs dictionaries, PANLIAN has the following benefits: it expels toxins, promotes blood circulation to remove blood...

2009-08-12 11:26:00

A research article to be published on August 7 , 2009 in the World Journal of Gastroenterology addresses this question. Study designed by Dr. El-Bokl and performed by Dr. Senousy and colleagues evaluated using spot urine Na/K ratio as an alternative. Forty patients with liver cirrhosis and ascites were admitted to Ain Shams University Hospital in Cairo, Egypt. The spot urine tests were compared to the standard 24-h urine collection test.Results showed adequate accuracy for the spot urine...

2009-04-01 09:00:00

Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation DEERFIELD, Ill., April 1 /PRNewswire/ -- Astellas Pharma US, Inc. today announced the commercial availability of Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose, a new premixed formulation. Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and...

2008-10-27 06:00:23

CHICAGO, Oct. 27 /PRNewswire/ -- ReachMD XM 157 announces a new "Medical Industry Feature of the Week" highlighting a vasopressin receptor antagonist and its effects on management of euvolemic and hypervolemic hyponatremia in the hospital setting. ReachMD XM 157, the first and only network for medical professionals, will air the program "AVP Antagonists: Turning the Tide Against Hyponatremia" four times a day October 27-31, November 10-14, and January 5-8. Healthcare professionals can tune...

2008-10-22 12:00:16

DEERFIELD, Ill., Oct. 22 /PRNewswire/ -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new premixed formulation of Vaprisol: Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose. Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and hypervolemic hyponatremia in hospitalized patients....

2008-09-04 15:00:36

DEAR DR. DONOHUE: I am writing this for my husband. About five years ago, he was diagnosed with hemochromatosis. The iron damaged his liver and pancreas. He is not a candidate for a liver transplant. In this past year, he has developed fluid in his abdomen, and for many months now, 5 liters (about 5 quarts) of fluid have to be removed weekly. The doctors suggest the TIPS procedure. What do you know of it? - B.S. ANSWER: Hemochromatosis is a genetic illness that causes the body to lose...

2008-07-04 12:00:28

Movetis has announced that M0002 is progressing to Phase IIb following positive results of a Phase IIa multiple-dosing trial for the treatment of ascites. The randomized, double blind, placebo controlled, dose-titration study explored the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatraemia. It was conducted in Belgium at multiple centers and enrolled 15 patients who were treated once daily with drug or placebo...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related